# Paclitaxel protein-bound particles

NDC: 69097-398
Generic name: Paclitaxel protein-bound particles
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20250415

FDA application: ANDA209657

## Active ingredients

- PACLITAXEL: 100 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-398"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-398
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15eba86c-d9de-42e6-bc95-70ba4c015e72